Anti-CD20 monoclonal antibodies: reviewing a revolution
2018 · Human Vaccines & Immunotherapeutics · 121 citations
https://doi.org/10.1080/21645515.2018.1508624
S
Stephen Opat
Monash Health(AU)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
356
Papers
11.0K
Citations
40
h-index
118
i10-index
Stephen Opat is an academic researcher from Monash Health. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & Chronic Lymphocytic Leukemia Research & Chronic Myeloid Leukemia Treatments. The author has an h-index of 40, co-authored 303 publications.
ORCID: 0000-0002-0308-6458Papers by this author
worksZanubrutinib for the treatment of relapsed or refractory mantle cell lymphoma
2021 · Blood Advances · 97 citations
https://doi.org/10.1182/bloodadvances.2020004074
Zanubrutinib Versus Ibrutinib in Symptomatic Waldenström Macroglobulinemia: Final Analysis From the Randomized Phase III ASPEN Study
2023 · Journal of Clinical Oncology · 91 citations
https://doi.org/10.1200/jco.22.02830
Zanubrutinib Versus Bendamustine and Rituximab in Patients With Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Median 5-Year Follow-Up of SEQUOIA
2024 · Journal of Clinical Oncology · 43 citations
https://doi.org/10.1200/jco-24-02265
Integrated clinical and genomic evaluation of guadecitabine (SGI-110) in peripheral T-cell lymphoma
2022 · Leukemia · 27 citations
https://doi.org/10.1038/s41375-022-01571-8
Comprehensive humoral and cellular immune responses to COVID-19 vaccination in adults with cancer
2024 · Vaccine · 13 citations
https://doi.org/10.1016/j.vaccine.2024.126547
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat